Bod CEO ‘assured’ agency will register over-the-counter CBD medication as insomnia trial progresses
Bod Science CEO Jo Patterson has mentioned the agency is “feeling assured” it’ll efficiently register a low-dose CBD insomnia product for over-the-counter (schedule 3) gross sales in Australia. Her optimistic…